Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

Finasteride 1 mg helps prevent more hair loss in men with male pattern baldness.

Use "female pattern hair loss" term, finasteride may help, more research needed.

Minoxidil foam promotes hair growth and reduces hair loss safely in men.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Targeted cancer therapies often cause serious skin problems that need careful management.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

People with psoriasis and depression have lower BDNF levels, which could help measure depression in those with psoriasis.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

New treatments focusing on immune pathways show promise for stubborn hair loss.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.